透過您的圖書館登入
IP:3.22.61.246
  • 期刊

卵巢顆粒細胞瘤的治療

The Treatment Options for Granulosa Cell Tumor of the Ovary

摘要


卵巢顆粒細胞瘤是一種少見且發展緩慢的惡性腫瘤,病灶多為第I期,預後良好,通常無需追加輔助治療。對手術後有復發的高危險因子、殘留病灶、無法切除的復發病灶,可使用化學治療,有需要時,可輔以放射線或荷爾蒙治療。對晚期或復發性病灶,亦可考慮使用荷爾蒙治療,或以bevacizumab做另一次替代治療法。患者需長期追蹤,因為有些GCT患者會在多年後才復發。

關鍵字

顆粒細胞瘤 卵巢 bevacizumab

並列摘要


Granulosa cell tumors of the ovary (GCTs) constitute a rare subgroup carrying a malignant potential, since they have the ability to recur and metastasize. GCTs are generally associated with a favorable prognosis, and are diagnosed as stage 1 diseases. Therefore, many patients do not need adjuvant treatment after surgical treatment. Some regimen of combination chemotherapy is an option for patients with residual tumor or a high risk of recurrence. Hormone therapy or bevacizumab appears to be a good treatment alterative for patients with advanced-stage or recurrent GCT. A prolonged post-therapeutic follow-up is necessary because of the risk of recurrences, late and exceptional for the adult form.

並列關鍵字

granulosa cell tumor ovary bevacizumab

延伸閱讀


國際替代計量